N-acetylcysteine prevents neointima formation in experimental venous bypass grafts

British Journal of Surgery

Volumn 96, Issue 8, 2009, Pages 941-950

  De Graaf, R ^a   Tintu, A ^a   Stassen, F ^b   Kloppenburg, G ^b   Bruggeman, C ^b   Rouwet, E ^b,c  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c Sittard Geleen Heerlen   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; INTERLEUKIN 6; INTERLEUKIN 8;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMORAL ARTERY; GRAFT FAILURE; HUMAN; HUMAN CELL; HYPEROXIA; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE; VEIN BYPASS; VEIN GRAFT;

ACETYLCYSTEINE; ANIMALS; ARTERIOVENOUS ANASTOMOSIS; BLOOD VESSEL PROSTHESIS; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; FEMORAL ARTERY; FREE RADICAL SCAVENGERS; MALE; MYOCYTES, SMOOTH MUSCLE; RATS; RATS, INBRED LEW; TUNICA INTIMA; VEINS;

EID: 68049108407     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.6659     Document Type: Article

References (41)

1. Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation 1998; 97: 916-931.
2. Gaudino M, Cellini C, Pragliola C, Trani C, Burzotta F, Schiavoni G et al. Arterial versus venous bypass grafts in patients with in-stent restenosis. Circulation 2005; 112(Suppl 9): 1265-1269.
3. Cox JL, Chiasson DA, Gotlieb AI. Stranger in a strange land: the pathogenesis of saphenous vein graft stenosis with emphasis on structural and functional differences between veins and arteries. Prog Cardiovasc Dis 1991; 34: 45-68.
4. Deng Z, Wang Y, Jiang K, Liu X, WuW, Gao S et al. Molecular cloning and characterization of a novel dehydrin gene from Ginkgo biloba. Biosci Rep 2006; 26: 203-215.
5. Yang Z, Oemar BS, Carrel T, Kipfer B, Julmy F, Luscher TF. Different proliferative properties of smooth muscle cells of human arterial and venous bypass vessels: role of PDGF receptors, mitogen-activated protein kinase, and cyclin-dependent kinase inhibitors. Circulation 1998; 97: 181-187.
6. Heistad DD. Oxidative stress and vascular disease: 2005 Duff lecture. Arterioscler Thromb Vasc Biol 2006; 26: 689-695.
7. Griendling KK, FitzGerald GA. Oxidative stress and cardiovascular injury: Part II: animal and human studies. Circulation 2003; 108: 2034-2040.
8. Madamanchi NR, Vendrov A, Runge MS. Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 2005; 25: 29-38.
9. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 2000; 86: 494-501.
10. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 2000; 87: 840-844.
11. Shi Y, Patel S, Davenpeck KL, Niculescu R, Rodriguez E, Magno MG et al. Oxidative stress and lipid retention in vascular grafts: comparison between venous and arterial conduits. Circulation 2001; 103: 2408-2413.
12. Hishikawa K, Luscher TF. Pulsatile stretch stimulates superoxide production in human aortic endothelial cells. Circulation 1997; 96: 3610-3616.
13. O'Brien JE Jr, Ormont ML, Shi Y, Wang D, Zalewski A, Mannion JD. Early injury to the media after saphenous vein grafting. Ann Thorac Surg 1998; 65: 1273-1278.
14. 2-production in the pig coronary artery. Circulation 1997; 96: 3593-3601.
15. Jones R, Zapol WM, Reid L. Pulmonary artery remodeling and pulmonary hypertension after exposure to hyperoxia for 7 days. A morphometric and hemodynamic study. Am J Pathol 1984; 117: 273-285.
16. Coflesky JT, Jones RC, Reid LM, Evans JN. Mechanical properties and structure of isolated pulmonary arteries remodeled by chronic hyperoxia. Am Rev Respir Dis 1987; 136: 388-394.
17. Roy S, Khanna S, Wallace WA, Lappalainen J, Rink C, Cardounel AJ et al. Characterization of perceived hyperoxia in isolated primary cardiac fibroblasts and in the reoxygenated heart. J Biol Chem 2003; 278: 47 129-47 135.
18. Hoch JR, Stark VK, Hullett DA, Turnipseed WD. Vein graft intimal hyperplasia: leukocytes and cytokine gene expression. Surgery 1994; 116: 463-470.
19. Hirsch GM, Karnovsky MJ. Inhibition of vein graft intimal proliferative lesions in the rat by heparin. Am J Pathol 1991; 139: 581-587.
20. Dilley RJ, McGeachie JK, Tennant M. The role of cell proliferation and migration in the development of a neo-intimal layer in veins grafted into arteries, in rats. Cell Tissue Res 1992; 269: 281-287.
21. Lee JS, Kypreos KE, Sonenshein GE. Synchronization of cultured vascular smooth muscle cells following reversal of quiescence induced by treatment with the antioxidant N-acetylcysteine. Exp Cell Res 1998; 239: 447-453.
22. Atkinson MC. The use of N-acetylcysteine in intensive care. Crit Care Resusc 2002; 4: 21-27.
23. Hayashi K, Takahata H, Kitagawa N, Kitange G, Kaminogo M, Shibata S. N-acetylcysteine inhibited nuclear factor-kappaB expression and the intimal hyperplasia in rat carotid arterial injury. Neurol Res 2001; 23: 731-738.
24. Ghigliotti G, Mereto E, Eisenberg PR, Martelli A, Orsi P, Sini D et al. N-acetyl-cysteine reduces neointimal thickening and procoagulant activity after balloon-induced injury in abdominal aortae of New Zealand white rabbits. Thromb Haemost 2001; 85: 724-729.
25. Sadowska AM, Manuel-Y-Keenoy B, De Backer WA. Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: discordant in vitro and in vivo dose-effects: a review. Pulm Pharmacol Ther 2007; 20: 9-22.
26. Desmarquest P, Chadelat K, Corroyer S, Cazals V, Clement A. Effect of hyperoxia on human macrophage cytokine response. Respir Med 1998; 92: 951-960.
27. Hjort MR, Brenyo AJ, Finkelstein JN, Frampton MW, LoMonaco MB, Stewart JC et al. Alveolar epithelial cell-macrophage interactions affect oxygen-stimulated interleukin-8 release. Inflammation 2003; 7: 137-145.
28. Park MS, Wallace HM. Hyperoxia influences mRNA expression of cytokines in cultured human umbilical vein endothelial cells. Yonsei Med J 1998; 39: 1-12.
29. Bhandari V, Elias JA. Cytokines in tolerance to hyperoxia-induced injury in the developing and adult lung. Free Radic Biol Med 2006; 41: 4-18.
30. Christiansen JF, Hartwig D, Bechtel JF, Klüter H, Sievers H, Schönbeck U et al. Diseased vein grafts express elevated inflammatory cytokine levels compared with atherosclerotic coronary arteries. Ann Thorac Surg 2004; 77: 1575-1579.
31. Yue TL, Wang X, Sung CP, Olson B, McKenna PJ, Gu JL et al. Interleukin-8. A mitogen and chemoattractant for vascular smooth muscle cells. Circ Res 1994; 75: 1-7.
32. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-126.
33. Shenberger JS, Dixon PS. Oxygen induces S-phase growth arrest and increases p53 and p21(WAF1/CIP1) expression in human bronchial smooth-muscle cells. Am J Respir Cell Mol Biol 1999; 21: 395-402.
34. Santilli SM, Wernsing SE, Lee ES. The effect of supplemental oxygen on the transarterial wall oxygen gradients at a prosthetic vascular graft to artery anastomosis in the rabbit. Ann Vasc Surg 2001; 15: 435-442.
35. Lappas M, Permezel M, Rice GE. N-Acetyl-cysteine inhibits phospholipid metabolism, proinflammatory cytokine release, protease activity, and nuclear factor-kappaB deoxyribonucleic acid-binding activity in human fetal membranes in vitro. J Clin Endocrinol Metab 2003; 88: 1723-1729.
36. Paterson RL, Galley HF, Webster NR. The effect of N-acetylcysteine on nuclear factor-kappa B activation, interleukin-6, interleukin-8, and intercellular adhesion molecule-1 expression in patients with sepsis. Crit Care Med 2003; 31: 2574-2578.
37. Li J, Tu HJ, Dai G, Dai YC, Wu Q, Shi QZ et al. N-acetyl cysteine inhibits human signet ring cell gastric cancer cell line (SJ-89) cell growth by inducing apoptosis and DNA synthesis arrest. Eur J Gastroenterol Hepatol 2007; 19: 769-774.
38. Porwol T, Ehleben W, Brand V, Acker H. Tissue oxygen sensor function of NADPH oxidase isoforms, an unusual cytochrome aa3 and reactive oxygen species. Respir Physiol 2001; 128: 331-348.
39. 2, and the 3 PHDs: how animal cells signal hypoxia to the nucleus. Cell 2001; 107: 1-3.
40. Sen CK, Khanna S, Roy S. Perceived hyperoxia: oxygen-induced remodeling of the reoxygenated heart. Cardiovasc Res 2006; 71: 280-288.
41. Roy S, Khanna S, Bickerstaff AA, Subramanian SV, Atalay M, Bierl M et al. Oxygen sensing by primary cardiac fibroblasts: a key role of p21(Waf1/Cip1/Sdi1). Circ Res 2003; 92: 264-271.